Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
This dynamic can trouble even the most skilled investors, but luckily for you, we started StockStory to help you navigate these trade-offs and uncover exceptional companies that break the mold. Keeping that in mind, here are three large-cap stocks with attractive long-term potential.
ResMed (RMD)
Market Cap: $30.44 billion
Founded in 1989 to address the then-underdiagnosed condition of sleep apnea, ResMed (NYSE: RMD) develops cloud-connected medical devices and software solutions that treat sleep apnea, COPD, and other respiratory disorders for home and clinical use.
Why Are We Fans of RMD?
- Constant currency growth averaged 9.1% over the past two years, showing it can expand globally regardless of the macroeconomic environment
- Additional sales over the last five years increased its profitability as the 15.2% annual growth in its earnings per share outpaced its revenue
- Free cash flow margin grew by 21.4 percentage points over the last five years, giving the company more chips to play with
ResMed is trading at $211.32 per share, or 17.4x forward P/E. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.
Ameriprise Financial (AMP)
Market Cap: $41.11 billion
Founded in 1894 and spun off from American Express in 2005, Ameriprise Financial (NYSE: AMP) provides financial planning, wealth management, asset management, and insurance products to help individuals and institutions achieve their financial goals.
Why Do We Love AMP?
- Share repurchases have amplified shareholder returns as its annual earnings per share growth of 23.9% exceeded its revenue gains over the last five years
- Impressive 18.7% annual tangible book value per share growth over the last two years indicates it’s building equity value this cycle
- Industry-leading 63.7% return on equity demonstrates management’s skill in finding high-return investments
Ameriprise Financial’s stock price of $457.32 implies a valuation ratio of 10.5x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
Allstate (ALL)
Market Cap: $57.14 billion
Born from a Sears, Roebuck & Co. initiative during the Great Depression with its famous "You're in good hands" slogan, Allstate (NYSE: ALL) is one of America's largest personal property and casualty insurers, offering protection for autos, homes, and personal property.
Why Does ALL Stand Out?
- Offerings and unique value proposition resonate with customers, as seen in its above-market 9.6% annual sales growth over the last five years
- Performance over the past two years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue
- Balance sheet strength has increased this cycle as its 34.9% annual book value per share growth over the last two years was exceptional
At $221.91 per share, Allstate trades at 1.8x forward P/B. Is now a good time to buy? See for yourself in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
